Angelini Pharma

As part of our virtual marathon in support of INTERNATIONAL BUREAU FOR EPILEPSY's #50MillionSteps campaign to raise awareness on epilepsy, we’ve involved our Global Medical Advisor Paloma Pérez-Domper, PhD to go over the basics of epilepsy together. We believe in raising awareness through information and education, both inside and outside our company, and involving our expert medical colleagues is one of the most efficient ways to do it. 🧠 From its definition to how it can affect people’s lives, here’s what we all should know about epilepsy. Let’s make every step count, together. 💜  #AngeliniPharma #EveryStepCloser #WithYouInMind 

Welcome back in 2025 with the fifth issue of Future Pills, our monthly dose of good news about the latest advancements in pharmaceuticals and science. This month, we discuss brain aging and risk factors for depression, we talk about the role of AI in different scenarios... and much more! If we have intrigued you, check out #FuturePills and subscribe for monthly updates on the latest news in the pharmaceutical industry. Be sure to share and help spread the word about research advancements!

We’re one step further in our virtual #50MillionSteps marathon, walking together with INTERNATIONAL BUREAU FOR EPILEPSY for their global campaign to raise awareness on epilepsy. As Angelini Pharma, we have now reached more than 5 million steps and it’s time to dispel some of epilepsy's most common myths. To do so, we involved our Senior Clinical Fellow John Paul Leach, who’s clearing out those doubts and false assumptions that often nurture stigma and discrimination. Walking together towards a brighter future. 💜 #AngeliniPharma #EveryStepCloser #WithYouInMind 

Our virtual marathon in support of the #50MillionSteps campaign organized by INTERNATIONAL BUREAU FOR EPILEPSY is now in full swing. With the participation of all our colleagues, we’re counting our steps every day for a good cause: to raise awareness about epilepsy and support those suffering from this serious, chronic, neurological disorder. So far, we’ve walked over 1 million steps — and we’re not stopping! Every step is a symbol of our commitment to reducing the stigma surrounding epilepsy. Together, we’re not only making strides but also spreading knowledge and compassion. Let’s keep moving forward, one step at a time, for a brighter future. 🌟 #AngeliniPharma #EveryStepCloser #WithYouInMind

We are delighted to once again join INTERNATIONAL BUREAU FOR EPILEPSY in their annual #50MillionSteps campaign to raise awareness about epilepsy and people living with this chronic neurological disease. As Angelini Pharma, we embrace the moment to frame our ongoing work to raise awareness of the disease within a global and collective cause, joining forces with like-minded individuals and companies towards a common goal: reducing the stigma and discrimination against epilepsy. Every year, our leaders and colleagues from all countries walk through January with enthusiasm for a good cause, and this year will be no exception. From now until February 10th, we will count our steps every day, in a big, shared virtual marathon, starting from our headquarters in Rome and running all the way to our farthest plant in Albany, Georgia. Last year we reached 7 million steps. Let's see where we get to this year! 💜 #AngeliniPharma #EveryStepCloser #WithYouInMind

Once again this year we are proud to participate in 50 Million Steps, the campaign ideated by the INTERNATIONAL BUREAU FOR EPILEPSY as a symbol of the fight against stigma and discrimination towards those living with epilepsy. To learn more about this campaign and about Angelini Pharma’s #50MillionSteps for 2025, don’t miss the special edition of #FuturePills.

It's with great pleasure that we introduce Radosław Pilipczuk as our new Angelini Pharma Romania Country Manager. With over 15 years of experience in sales and business leadership across the pharmaceutical industry, Radosław brings a wealth of expertise in both general medicine and specialty pharmaceuticals. His successful track record at Angelini Pharma Polska, where he has led strategic business units across various therapeutic areas, makes him the ideal person to lead our operations in Romania. As Radosław says, “Collaboration, active listening, and empowering ideas from within the organization have consistently been the foundation of my leadership approach, and they will remain central as we move forward. I strongly believe, together with my new Romanian team, we will continue to grow the business, nurture our people, and promote a culture of excellence and high performance.” Welcome aboard, Radosław! We look forward to achieving great things together. 🚀 #AngeliniPharma #EveryStepCloser

We’re proud to share that we have been recognized as a Top Employer 2025 for the 6th consecutive year! 🎉 This recognition brings our ambition to life: making Angelini Pharma one of the top ten European companies. Being certified by an external organization for our HR practice holds significant meaning in our daily work and provides all our employees with a senso of trust and engagement.­­ 🏆We are 10th Top Employer Europe for the very first time!🏆   🏅 3rd Top Employer in Turkey 🏅 5th Top Employer in Portugal 🏅 14th Top Employer in Italy   This recognition inspires us to keep raising the bar and striving for excellence, every single day.   #AngeliniPharma #EveryStepCloser #WinAsOne #EvolveOurCulture #TopEmployer2025

A year to remember, a future to envision. From groundbreaking research to impactful partnerships, 2024 has been a remarkable year of innovation, collaboration, and progress for Angelini Pharma. Driven by our unwavering commitment to well-being and holistic health, we’ve worked tirelessly to create meaningful value for patients, consumers, the scientific community, institutions, and the entire healthcare ecosystem across the fields of Brain and Consumer Health.   None of this would have been possible without the dedication, passion, and expertise of our incredible teams across the world. 💙 As we close the year, we reflect with pride on the extraordinary milestones we’ve achieved together and look forward with gratitude and excitement to 2025 but always to make a difference, one step at a time.   #AngeliniPharma #EveryStepCloser

Our Inside LIFE-GREENAPI Project video series continues, exploring how we’re reducing the environmental impact of pharma production. In this third episode, Kristie Tjokro, PhD candidate at Leiden University, explains how the Life Cycle Assessment (LCA) methodology is used to quantify the environmental impact associated with the life cycle of API, from raw materials to the production output. The second part of the video is available on our YouTube channel: https://lnkd.in/d4FMjdnY #AngeliniPharma #EveryStepCloser